Content uploaded by Adewale Ayodeji Adeyeye
Author content
All content in this area was uploaded by Adewale Ayodeji Adeyeye
Content may be subject to copyright.
Available via license: CC BY-NC
Content may be subject to copyright.
VeterinariaItaliana,2011,47(1),35‐40
©IstitutoG.Caporale2011www.izs.it/vet_italianaVol.47(1),VetItal35
RiftValleyfever:theNigerianstory
AdewaleA.Adeyeye(1),PiusS.Ekong(2)&NicholasN.Pilau(1)
Summary
RiftValleyfever(RVF)isanarthropod‐borne
zoonoticdiseaseoflivestock.Itischaracterised
byfever,salivation,abdominalpain,diarrhoea,
mucopurulenttobloodynasaldischarge,
abortion,rapiddecreaseinmilkproduction
anddeathinanimals.Infectedhumans
experienceaninfluenza‐likeillnessthatis
characterisedbyfever,malaise,headaches,
nauseaandepigastricpainfollowedby
recovery,althoughmortalitycanoccur.RVF
wasthoughttobeadiseaseofsub‐Saharan
AfricabutwiththeoutbreaksinEgyptandthe
ArabianPeninsula,itmaybeextendingits
rangefurtherafield.Virologicalandsero‐
logicalevidenceindicatesthatthevirusexists
inNigeriaand,withthewarningsignalsentby
internationalorganisationstocountriesin
Africaaboutanimpendingoutbreak,
co‐ordinatedresearchbetweenveterinarians
andphysiciansinNigeriaisadvocated.
Keywords
Abortion,Africa,RiftValleyfever,Livestock
handlers,Nigeria,Publichealth,Virus,
Zoonosis.
Rapportosullafebbredella
ValledelRiftinNigeria
Riassunto
LafebbredellaValledelRift(RVF)èunamalattia
zoonosicadelbestiameveicolatadaartropodi.È
caratterizzatadafebbre,salivazione,dolore
addominale,diarrea,scolonasaledamucopurulento
aematico,aborto,rapidadiminuzionenella
produzionelatteaemorteneglianimali.Isoggetti
umaniinfettimanifestanounamalattiasimile
all’influenzacaratterizzatadafebbre,malessere,
attacchidicefalea,nauseaedoloreepigastrico
seguitidallaguarigione,sebbenepossaverificarsi
unamortalità.LaRVFeraritenutaunamalattia
dell’Africasub‐sahariana,maconifocolaiepidemici
inEgittoenellapenisolaarabicaèpossibilechestia
ampliandoancoradipiùilsuoraggio.L’evidenza
virologicaesierologicaindicacheilvirusèpresente
inNigeriaeconsistemadiallertainviatidalle
organizzazioniinternazionaliallenazioniafricane
riguardanteunimminentefocolaioepidemico,è
urgenteinquestopaeseunaricercacoordinatafra
veterinariemedici.
Parolechiave
Aborto,Addettialbestiame,Africa,Febbre
dellaValledelRift,Nigeria,Salutepubblica,
Virus,Zoonosi.
Introduction
RiftValleyfever(RVF)isalsoknownas
enzootichepatitisofsheepandcattle.Itisan
acute,infectiousandzoonoticdiseaseof
predominantlycattle,sheep,goat,camels,
Africanbuffalo(Synceruscaffer)andhumans.
Thediseaseiscausedbyanarbovirusandis
associatedwithperiodicoutbreaksthatmostly
occurontheAfricancontinent.Itisafebrile
diseasethatisaccompaniedbyabortionin
livestockandaseverefatalhaemorrhagic
syndromeinhumanshasbeenobserved(11).It
isanotifiablediseaseandisspreadbythebite
ofmosquitoes.
Thediseasewasfirstreportedamongsheepin
KenyabyMontgomeryin1912andStordyin
1913(4),butthediseasewasnotisolateduntil
1931(25).Presently,virologicalandserological
evidencesuggeststhatthevirusexists
(1) Department of Veterinary Medicine, Surgery and Theriogenology, Usmanu Danfodiyo University, P.M.B. 2254,
Sokoto, Nigeria
ayo4wale@hotmail.com
(2) Central Diagnostic Department, National Veterinary Research Institute, P.M.B. 01, Vom, Jos, Plateau State, Nigeria
AreportonRiftValleyfeverinNigeriaAdewaleA.Adeyeye,PiusS.Ekong&NicholasN.Pilau
36 Vol.47(1),VetItalwww.izs.it/vet_italiana©IstitutoG.Caporale2011
throughoutsub‐SaharanAfricaandMadagascar
and,inthelightofitsrecurrenceinEgyptin
1993and2003(5,7,9,39),itmaybeextending
itsrangeevenfurther.InSeptember2000,
casesofunexplainedhaemorrhagicfeverin
humansandassociatedanimaldeathsin
south‐westernSaudiArabiaandYemenwere
confirmedasRVFand,bymid‐January2001,
thediseasehadclaimedseveralhumanlivesin
thesecountries(1);theoutbreakonthe
ArabianPeninsularepresentsthefirstcasesof
RVFoutsideAfrica.In2007,anoutbreak
occurredinKenyaandSomaliawhereover
404humancases,including118deaths,were
reported(10).InSouthAfrica,thelastoutbreak
occurredinMay2010;preliminary
investigationrevealedthat186humanswere
confirmedRVFcasesoutofwhich18died(40).
Anoverviewofthediseaseisnecessarygiven
climatechangesthatfavourpossibleoutbreaks
(20,24)andthewarningsignalsdespatchedto
countriesinAfricabytheFoodand
AgricultureOrganizationandWorldHealth
Organization(16).
Aetiology
TheRVFvirusisthecausalagentofthe
disease.ThevirusisofthegenusPhlebovirus,
familyBunyaviridae(26).Itisanenveloped,
single‐strandednegative‐senseRNAvirusthat
measuresbetween80nmand120nmin
diameterwiththreesegmentsnamedS(small),
M(medium)andL(large)(8).
Transmission
RVFisamosquito‐bornedisease(2).Aedesis
thespeciesofmosquitothatisincriminatedin
biologicaltransmission(36,37),although
Glossina,Culicoides,Culexspeciesandsandflies
mayplaylimitedrolesinbiologicaland
mechanicaltransmission(21,25).Apartfrom
thesevectors,thediseasehasbeenreportedto
spreadthroughneedleinoculation,contact
withinfectedanimalsorhumanswithhigh
prevalenceduringperiodsofheavyrainfall(2,
34,38,42).Experimentaltransmissioninsheep
frominfectedmouseserumhasbeenreported
(35).Riskgroupsincludeanimalhandlers,
particularlythoseassistinganimalsduring
abortions/parturition,thosetreatingsick
animalsandthosenursingaffectedpeople,
particularlyinareaswithoutbreaks(38).
Humansmaybeinfectedbydirectandindirect
contactwithinfectedanimalsaswellasby
bloodfromfoetusesorslaughteredanimals
(17).Transmissionisalsopossiblebymosquito
bite(6,25)andingestionofunpasteurisedor
uncookedmilkfrominfectedanimals(5,31).
Casesofverticaltransmissionhavealsobeen
reported(3,6).
Clinicalsigns
Theincubationperiodforthediseaseisshort.
Itrangesfrom1to6daysinanimals,although
itisshorterinyoungeranimals,andbetween4
to7daysinhumans(2,33).Inadultanimals,it
ischaracterisedbyfeverwithin24hof
infectionthatlastsbetween6and7daysbut
peaksbetweendays2and4postinfection;
viraemiacoincideswithfeverwhichpeakson
day3postinfection(29).Abortionsoccurin
pregnantanimalsandsigns,suchassalivation,
abdominalpain,diarrhoea,mucopurulentto
bloodynasaldischargeandrapiddecreasein
milkproductioninparticular,areobservedin
dairycows(2,25,35,41).Inyoungeranimals,
lambsandneonates,deathusuallyoccurs
within24hbutsignsoffever,depression,
anorexiaandabdominalpainareprominent
priortodeath(33).
Thediseaseinhumansisinfluenza‐likeandis
characterisedbyfever,malaise,headache,
nausea,epigastricpain,sensationoffullness
overtheregionoftheliver,followedby
completerecovery.However,itmayevolve
intoahaemorrhagicfeversyndrome,meningo‐
encephalitisorevenaffecttheeyes(2,19,25,
32,33).
Animalsthatdieofthediseaseshowextensive
livernecrosisandenlargementatpost‐mortem
examination,withoedemaandhaemorrhages
onthewallofthegallbladder.Innewborn
lambsinfectedinutero,thecontentsofthe
abomasumandsmallintestineareofa
chocolate‐browncolour(8).Inaddition,the
lambwillexhibitgeneralisedhepaticnecrosis.
AdewaleA.Adeyeye,PiusS.Ekong&NicholasN.PilauAreportonRiftValleyfeverinNigeria
©IstitutoG.Caporale2011www.izs.it/vet_italianaVol.47(1),VetItal37
Diagnosis
Diagnosisisperformedbyisolatingand
identifyingthevirusorbyobservinga
fourfoldriseinspecificneutralisingantibody
titrebetweenacuteandconvalescentsera.
Uponpost‐mortemexamination,characteristic
histopathologicalfindingsoflivernecrosisin
allsusceptibleanimalsoftenprovidethefirst
cluetothedisease.Confirmatorydiagnosisis
byserologyusingIgMorIgGantibody‐specific
enzyme‐linkedimmunosorbentassay(ELISA),
complimentfixation,viralneutralisation,
haemagglutinationinhibitionandtheplaque
reductiontest.
Differentialdiagnosisinanimalsincludesthe
following:
bacterialsepticaemias
poisoning
rinderpest
pestedespetitsruminants(PPR)
bluetongue
bovineephemeralfever
enterotoxemiaofsheep
brucellosis
campylobacteriosis
toxoplasmosis
trichomoniasis
heartwater
otherabortificientcausalagents.
Epidemiology
RVFwasthoughtobeadiseaseofsub‐Saharan
Africa,butthediseasehasspreadtoEastand
CentralAfrica(14)andtowesternSaudi
ArabiaandYemen(25).Inadditiontocattle
andsheep,otheranimalshavebeenreported
tobesusceptibletothedisease.Antibodies
againstthediseasehavebeendetectedin
Africanbuffalo,blackrhino(Dicerosbicornis),
lesserkudu(Tragelaphusimberbis),impala
(Aepycerosmelampus),Africanelephant
(Loxodontaafricana),kongoni(Alcelaphus
buselaphuscokii),waterbuck(Kobusellipsiprymnus)
(11),goats,camelsandhorses(29)but
evidenceoftherolethattheseanimalsplayin
maintainingthevirusbetweenoutbreaksis
stillunknown.However,LaBeaudetal.(23)
reportedthatoldermaleslivinginrural
villagesandwhohaddisposedofanimal
abortuseswereresponsibleforinter‐epidemic
transmissioninKenya.
InNigeria,Fergusonfirstisolatedthevirus
fromanimals(15).Subsequentserological
evidencesuggeststhatthevirusmaybe
circulatingatlowlevelsindomesticlivestock
andinthehumanpopulation,particularly
amonglivestockworkersandwildliferangers
(28).Cattle,sheepgoatsandcamelsinthe
StatesofKadunaandSokotohaverevealed
significantantibodytitresintheirserum(12).
Serologicalprevalenceofthediseaseinthese
animalspeciesinIle‐IfeandIbadanwas
observedbyOlaleyeetal.(27)whoconfirmed
theexistenceofthediseaseinNigeria.Apart
fromtheseobservations,experimental
infectionwithdifferentstrainsofthediseasein
threeindigenousbreedsofsheepinNigeria,
namely:theWestAfricandwarf,Yankasaand
Oudahaveresultedinfataldisease(13).
Furtherstudiesarethereforerequiredto
determinethepresentstatusofthediseasein
Nigeria.
Treatment
Thereisnotreatmentforanimals,butaninitial
50mg/kgloadingdoseofribavirinfollowedby
10mg/kgat8hintervalfor9dayshasbeen
suggestedtocontributetothepreventionorto
providetherapyinhumans(30).
Preventionandcontrol
Preventionisbestachievedbyvaccination.A
live‐attenuatedandkilledvaccineisavailable
forlivestock.Thelive‐attenuatedSmithburn
strainprovideslong‐lastingimmunitybutit
producesateratogeniceffectinsheepwhen
administeredinthefirsttrimester(22)anditis
abortogenicinpregnantewes(25).Apartfrom
these,thevaccinehasbeendocumented
experimentallynottoprotectagainstthe
NigeriaandLunyostrainsofthevirusinWest
Africandwarfsheep(35).Thelivevirus
vaccinesarerecommendedforuseinendemic
areas,whilethekilledvaccinesare
recommendedforuseoutsideendemicareas.
Aformalin‐inactivatedvaccineissafefor
AreportonRiftValleyfeverinNigeriaAdewaleA.Adeyeye,PiusS.Ekong&NicholasN.Pilau
38 Vol.47(1),VetItalwww.izs.it/vet_italiana©IstitutoG.Caporale2011
pregnantewesbutprovidesonlyshort‐term
immunityandhencerequiresabooster
inoculationtomaintaindurableimmunity.The
onlyvaccineclearedforhumanuseisthe
killedproductavailableonlyfromtheUnited
StatesArmyMedicalResearchandMaterial
Command(USAMRMC).Itisaninitialthree‐
doseseriesforprotectiveimmunitywith
annualboosterinoculationsrequiredto
maintainthatimmunity(25).Thisvaccinehas
beenusedtoelicitimmuneresponseamong
laboratorystaffinNigeria(18).
Vectorcontrolofmosquitopopulationsand
restrictedmovementsduringoutbreakscanbe
effectivemeasuressinceanimalshavehigh
levelsofviraemiaandconsequentlyamplify
transmission.Educationalcampaignsto
preventhumanexposuretoinfectedanimal
tissuesorabortusesandexposuretomosquito
vectorsareeffective.Vaccinationofpeoplein
high‐riskoccupationsisequallyeffectivein
combatinganoutbreak.
Conclusion
Inconclusion,RVFisemerginginnewareas
andthereissomere‐emergenceofthevirusin
previouslyaffectedareas.Hence,thereisa
strongneedfortheAfricancontinentto
strengthenregionalandnationalwarning
systems,suchasco‐ordinatedresearch
betweenveterinariansandphysicians,which
willcontributetothepreventionofan
epidemic.
References
1. Abdo-Salem S., Gerbier G., Bonnet P., Al-Qadasi M., Tran A., Thiry E., Al-Eryni G. & Roger F. 2006.
Descriptive and spatial epidemiology of Rift Valley fever in Yemen 2000-2001. Ann NY Acad Sci,
1081, 240-242.
2. Abdulkadir I.A. 1989. Rift Valley fever. In Infectious diseases of livestock in Nigeria. Ahmadu Bello
University Press Limited, Zaria, 195-197.
3. Adam I. & Karsany M.S. 2008. Case report: Rift Valley fever with vertical transmission in a pregnant
Sudanese woman. J Med Virol, 80 (5), 929.
4. Anon. 2010. Rift Valley fever. RedGems (Re-Emergent Diseases Global Environment Monitoring from
Space) (www.redgems.org/spip.php?rubrique6 accessed on 30 December 2010).
5. Anon. 2010. Rift Valley fever (RVF): transmission to humans. East African Community (EAC), Health,
EAC Secretariat, Arusha (www.eac.int/health/index.php?option=com_content&view=article&id=
109%3Arift-valley-fever-rvf-transmissions-to-humans&catid=30%3Arvf&Itemid=33 accessed on
10 December 2010).
6. Arishi H.M., Aqeel A.Y. & Al-Hazmi M.M. 2006. Vertical transmission of fatal Rift Valley fever in a
newborn. Ann Trop Paediatr, 26 (3), 251-253.
7. Arthur R.R., El-Sharkawy M.S., Cope S.E., Bostros B.A., Oun S., Morrill J.C., Shope R.E., Hibbs R.G.,
Darwish M.A. & Imam I.Z. 1993. Recurrence of Rift Valley fever in Egypt. Lancet, 342 (8880), 1149-
1150.
8. Center for Infectious Disease Research & Policy (CIDRP) 2010. Rift Valley fever. CIDRP, University of
Minnesota, St Paul, Minnesota (www.cidrap.umn.edu/cidrap/content/biosecurity/ag-biosec/anim-
disease/rvf.html accessed on 10 December 2010).
9. Centers for Disease Control and Prevention (CDC) 1994. Rift Valley fever – Egypt, 1993. Morb Mortal
Wkly Rep, 43 (38), 693-700.
10. Centers for Disease Control and Prevention (CDC) 2007. Rift Valley fever outbreak – Kenya,
November 2006-January 2007. Morb Mortal Wkly Rep, 56 (4), 73-76.
11. Evans A., Gakuya F., Paweska J.T., Rostal M., Akoolo L., Van Vuren P.J., Manyibe T., Macharia J.M.,
Ksiazek T.G., Feikin D.R., Breiman R.F. & Kariuki Njenga M. 2008. Prevalence of antibodies against Rift
Valley fever virus in Kenyan wildlife. Epidemiol Infect, 136 (9), 1261-1269.
12. Ezeifeka G.O., Umoh J.U., Belino E.D. & Ezeokoli C.D. 1982. A serological survey for Rift Valley fever
antibodies in food animals in Kaduna and Sokoto States of Nigeria. Int J Zoonoses, 9 (2), 147-151.
13. Fagbami A.H., Tomori O., Fabiyi A. & Isoun T.T. 1975. Experimental Rift Valley fever in West African
dwarf sheep. Res Vet Sci, 18 (3), 334-335.
AdewaleA.Adeyeye,PiusS.Ekong&NicholasN.PilauAreportonRiftValleyfeverinNigeria
©IstitutoG.Caporale2011www.izs.it/vet_italianaVol.47(1),VetItal39
14. Faye O., Diallo M., Diop D., Bezeid O.E., Ba H., Niang M., Dia I., Mohammed S.A., Ndiaye K., Diallo D.,
Ly P.O., Diallo B., Nabeth P., Simon F., Lo B. & Diop O.M. 2007. Rift Valley fever outbreak with East
Central African virus lineage in Mauritania, 2003. Emerg Infect Dis, 13 (7), 1016-1023.
15. Ferguson W. 1959. Identification of Rift Valley fever in Nigeria. Bull Epiz Dis Afr, 7, 317-318.
16. Food and Agriculture Organization (FAO) 2008. Climate models predict increased risk of
precipitation in the Horn of Africa for the end of 2008. Empress Watch. FAO, Rome, 4 pp
(ftp://ftp.fao.org/docrep/fao/011/aj129e/aj129e00.pdf accessed on 3 November 2010).
17. Food and Agriculture Organization (FAO) 2010. Rift Valley fever: transmission and spread. Causes of
transmission. FAO, Rome (www.fao.org/docrep/006/y4611e/y4611e04.htm#TopOfPage accessed
on 10 December 2010).
18. Frank-Peterside N. 2000. Response of laboratory staff to vaccination with an inactivated Rift Valley
fever vaccine – TSI-GSD. Afr J Med Sci, 29 (2), 89-92.
19. Gerdes G.H. 2004. Rift Valley fever. Rev Sci Tech, 23 (2), 612-623.
20. Gould E.A. & Higgs S. 2009. Impact of climate change and other factors on emerging arbovirus
diseases. Trans R Soc Trop Med Hyg, 103 (2), 109-121.
21. Hoch A.L., Gargan T.P. & Bailey C.L. 1985. Mechanical transmission of Rift Valley fever virus by
hematophagous Diptera. Am J Trop Med Hyg, 34 (1), 188-193.
22. Hunter P., Erasmus B.J. & Vorster J.H. 2002. Teratogenicity of mutagenised Rift Valley fever virus
(MVP 12) in sheep. Onderstepoort J Vet Res, 69 (1), 95-98.
23. LaBeaud A.D., Muchiri E.M., Ndzovu M., Mwanje M.T., Muiruri S., Peters C.J. & King C.H. 2008.
Interepidemic Rift Valley fever seropositivity, northeastern Kenya. Emerg Infect Dis, 14 (8), 1240-1246.
24. Martin V., Chevalier V., Ceccato P., Anyamba A., De Simone L., Lubroth J., de La Rocque S. &
Domenech J. 2008. The impact of climate change on the epidemiology and control of Rift Valley
fever. Rev Sci Tech, 27 (2), 413-426.
25. Morrill J.C. 2001. Rift Valley fever in animals and humans. In Zoonoses, animal diseases that affect
man (D.E. Goodman, ed.). Christian Veterinary Missions, Seattle, 49-56.
26. Olaleye O.D., Baigent C.L., Mueller G., Tomori O. & Schmitz H. 1992. Electron microscopic
identification of Zinga virus as a strain of Rift Valley fever virus. Res Virol, 143 (3), 215-218.
27. Olaleye O.D., Tomori O., Fajimi J.L. & Schmitz H. 1996. Experimental infection of three Nigerian
breeds of sheep with the Zinga strain of the Rift Valley fever virus. Rev Elev Med Vet Pays Trop, 49 (1),
6-16.
28. Olaleye O.D., Tomori O., Ladipo M.A. & Schmitz H. 1996. Rift Valley fever in Nigeria: infections in
humans. Rev Sci Tech, 15 (3), 923-935.
29. Olaleye O.D., Tomori O. & Schmitz H. 1996. Rift Valley fever in Nigeria: infections in domestic animals.
Rev Sci Tech, 15 (3), 937-946.
30. Peters C.J., Reynolds J.A., Slone T.W., Jones D.E. & Stephen E.L. 1986. Prophylaxis of Rift Valley fever
with antiviral drugs, immune serum, an interferon inducer and a macrophage activator. Antiviral Res,
6 (5), 285-297.
31. Seifert H.S.H. 1996. Vector-borne diseases. In Tropical animal health, First Ed. Kluwer Academic
Publishers, Dordrecht, 246.
32. Shawky S. 2000. Rift Valley fever. Saudi Med J, 21 (12), 1109-1115.
33. Smith H.A., Jones T.C. & Hunt R.D. 1972. Diseases caused by viruses – Rift Valley fever. In Veterinary
pathology, 4th Ed. Lea and Febiger, Philadelphia, 471-474.
34. Thonnon J., Picquet M., Thiongane Y., Lo M., Sylla R. & Vercruysse J. 1999. Rift Valley fever
surveillance in the lower Senegal River basin: update 10 years after the epidemic. Trop Med Int
Health, 4 (8), 580-585.
35. Tomori O. 1979. Clinical, virological and serological response of the West African dwarf sheep to
experimental infection with different strains of Rift Valley fever virus. Res Vet Sci, 26 (2), 152-159.
36. Turell M.J., Presley S.M., Gad A.M., Cope S.E., Dohm D.J., Morrill J.C. & Arthur R.R. 1996. Vector
competence of Egyptian mosquitoes for Rift Valley fever virus. Am J Trop Med Hyg, 54 (2), 136-139.
37. Turell M.J., Linthicum K.J., Patrican L.A., Davies F.G., Kairo A. & Bailey C.L. 2008. Vector competence
of selected African mosquitoes (Diptera: Culicidae) species for Rift Valley fever virus. J Med Entomol,
45 (1), 102-108.
AreportonRiftValleyfeverinNigeriaAdewaleA.Adeyeye,PiusS.Ekong&NicholasN.Pilau
40 Vol.47(1),VetItalwww.izs.it/vet_italiana©IstitutoG.Caporale2011
38. Wilson M.L., Chapman L.E., Hall D.B., Dystra E.A., Ba K., Zeller H.G., Traoré-Lamina M., Henvy J.P.,
Linthicum K.J. & Peter C.J. 1994. Rift Valley fever in rural northern Senegal: human risk factors and
potential vectors. Am J Trop Med Hyg, 50 (6), 663-675.
39. World Health Organisation (WHO) 2003. Rift Valley fever in Egypt. WHO, Geneva (www.who.int/
csr/don/2003_09_02a/en/ accessed on 10 December 2010).
40. World Health Organisation (WHO) 2010 Rift Valley fever in South Africa – update 2, WHO, Geneva
(www.who.int/csr/don/2010_05_12/en/index.html accessed on 10 December 2010).
41. Yedloutschnig R.J., Dardiri A.H., Mebus. C.A. & Walker J.S. 1981. Abortion in vaccinated sheep and
cattle after challenge with Rift Valley fever virus. Onderstepoort J Vet Res, 69 (1), 95-98.
42. Zeller H.G., Fontenille D., Fontenille D., Traoré-Lamizana M., Thiongane Y. & Digoutte J.-P. 1997.
Enzootic activity of Rift Valley fever virus in Senegal. Am J Trop Med Hyg, 56 (3), 265-272.